HP 163
Alternative Names: HP-163Latest Information Update: 28 Sep 2024
Price :
$50 *
At a glance
- Originator Hercules Pharmaceuticals
- Class Antineoplastics; Antivirals; Small molecules
- Mechanism of Action Aryl hydrocarbon receptor antagonists; Cytochrome P-450 enzyme system modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; COVID 2019 infections; Dengue; Zika virus infection
Most Recent Events
- 28 Sep 2024 No recent reports of development identified for preclinical development in COVID-2019-infections in Netherlands (PO)
- 28 Sep 2024 No recent reports of development identified for preclinical development in Dengue in Netherlands (PO)
- 28 Sep 2024 No recent reports of development identified for preclinical development in Zika-virus-infection in Netherlands (PO)